Hangzhou Alltest Biotech Co., Ltd. (688606.SS)

75.00 +0.89 (+1.20%) At close: 03:00PM CST

Hangzhou Alltest Biotech Co., Ltd.

Building 3, 4, 5
No. 550, Yinhai Street, Baiyang Street Hangzhou Economic and Tech Dev Zone Jianggan District
Hangzhou 310018
China
86 57 1562 07860
https://www.alltests.com.cn

Sector(s): Healthcare
Industry: Medical Instruments & Supplies
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Fei Gao	Chairman & GM	N/A	N/A	1974
Ms. Yanping Fu	CFO & Secretary of the Board of Directors	N/A	N/A	1978
Mr. Weike Lu	Deputy GM & Director	N/A	N/A	1981

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Hangzhou Alltest Biotech Co., Ltd. engages in the research, development, production, and sale of in vitro diagnostic reagents in China and internationally. The company offers rapid diagnostic reagents, including drug and drug abuse, infectious disease, women's health, tumor marker, and cardiac marker testing products. Its products include COVID-19 antigen and antibody tests; veterinary tests; fluorescence immunoassay tests and analyzers; urine analysis solutions, biochemistry reagents, VTM, blood glucose monitoring systems, and HB hemoglobin test meters. In addition, the company offers SARS-COV-2 RT-qPCR assays, virus specimen stabilizers, and viral DNA/RNA extraction kits; and other test products. Its products are used in clinical testing, on-site testing, personal health management, and other fields. Hangzhou Alltest Biotech Co., Ltd. was founded in 2009 and is based in Hangzhou, China.

Corporate governance

Hangzhou Alltest Biotech Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.